A longitudinal population study of 1462 women aged 38-60 was carried out from 1968-9 to 1980-1 in Gothenburg, Sweden. The initial and follow up examinations included questions concerning history of diabetes and antihypertensive treatment. A considerably increased risk of developing diabetes was observed for subjects with hypertension taking diuretics (895 patient years), subjects taking fi blockers (682 patient years), and subjects taking a combination of diuretics and blockers (281 patient years) compared with subjects not taking antihypertensive drugs (13 855 control years). When diuretics and , blockers were compared no difference was found in relative risk.
Introduction
Although the development of diabetes has been postulated to be a possible side effect of diuretic treatment, no study has been able to show definitely whether there is a causal relation between diuretics and diabetes. In addition, some studies have indicated an increased incidence of diabetes in patients taking blockers.1 2If the incidence of diabetes is increased in subjects taking different types of antihypertensive drugs the reason might be an association between the antihypertensive state and diabetes rather than between antihypertensive drugs and diabetes. We studied the incidence of diabetes over 12 years in a defined population sample. We compared subjects taking antihypertensive drugs with those not taking them. A further subdivision was made to compare subjects taking diuretics with subjects taking 5 blockers.
obtained about antihypertensive treatment and prevalence of diabetes by telephone interview or letter from most of the refusers in the follow up studies and most of those who had moved from the area. Thus we succeeded in interviewing 1406 women (1302 participants) concerning antihypertensive treatment and diabetes in the follow up study in 1974-5 (97-90o of all survivors) and 1351 women (1154 participants) in 1980-1 (97 40, of all survivors). Women who died during the six years between 1968-9 and 1974-5 (n---26) or between 1974-5 and 1980-1 (n-49) were excluded from analysis of the respective six year period. In none of the women who died had diabetes been diagnosed between her last participation in the population study and her death. Non-participants in the follow up studies from whom no information could be obtained were also excluded. Detailed information about antihypertensive treatment being received in the population sample at the time of each of the three studies has been reported previously.5 Twelve women in whom diabetes had already been diagnosed at the beginning of the study in 1968-9 were excluded from the start. Table II 
Results
Diabetes was diagnosed in 43 initially non-diabetic women between 1968-9 and 1980-1. At the time of the first study four of these 43 were aged 38; 10, 46; 18, 50; eight 54; and three 60. Of these 43 women, 25 were diagnosed as having diabetes while taking antihypertensive drugs and 18 while not.
A multivariate analysis was carried out in which age, initial fasting blood glucose concentration, and initial body mass index were taken into consideration as background variables. The correlation between antihypertensive treatment and incidence of diabetes was still significant when age, fasting blood glucose concentration, and body mass index were taken into consideration (p-000006). 5 7)). Again there were no significant differences. Non-participants in the follow up studies excluded 
Discussion
We found an appreciable increase in the incidence of diabetes in subjects taking diuretics or 3 blockers or a combination of diuretics and D3 blockers compared with women who were not taking antihypertensive drugs. No significant differences were observed between women taking diuretics and women taking D blockers. As very few women in Gothenburg during these 12 years were taking any other antihypertensive drugs5 con- clusions concerning the incidence of diabetes could be drawn for only diuretics and 'i blockers. There are fev recent data on the incidence of diabetes in subjects with untreated arterial hypertension as leaving arterial hypertension untreated is now considered to be ethically unacceptable. Previous studies have indicated an association between untreated hypertension and diabetes, as reviewed, for example, by Barrett-Connor et all"' and Drury,' but the association was never as strong as that observed in the present study of hypertensive subjects taking antihypertensive drugs. We therefore feel justified in believing that an association exists between treatment with antihypertensive drugs and diabetes, at least as far as diuretics and M blockers are concerned; final proof, however, is still lacking. It is also worth noting that in this respect our findings showed no difference between diuretics and M blockers.
Ever since diuretics were introduced as antihypertensive drugs their possible association with diabetes has been discussed, and many papers have been published on the possible relation between diuretics and impaired glucose tolerance or clinical diabetes. Such studies have been reviewed, for example, by our group'2 and by Furman"; interest has not, however, been focused on 'S blockers in the same way.
One main drawback of our study is that the subjects were not randomised to one or other drug. The drugs were given according to the individual doctor's clinical judgment. This necessitates caution when interpreting the results. With respect, however, to the appreciable differences observed in comparison with women not taking antihypertensive drugs and, in addition, the similarities before treatment between subjects who started different antihypertensive drugs, the results cannot be disregarded.
The main advantages of this study are that the women were representative of women in the general population, they were carefully followed up, a long follow up period was used, and the number of subjects disappearing from the study over the 12 years was small.
Our findings raise the important question of whether the results should be taken as an indication for avoiding diuretics and 31 blockers in the treatment of arterial hypertension. Very limited information exists concerning the risk of diabetes when using other types of antihypertensive treatment, and we therefore think that other drugs must be shown to be different in this respect before they can be recommended, as being less diabetogenic, as drugs of choice in the treatment of arterial hypertension.
Despite the increased risk of clinical diabetes that we observed, we found that diuretics and ' blockers caused few side effects during the long term follow up described in this paper. In addition, mortality was, if anything, lower among women who were referred for antihypertensive treatment at the time of the initial study than in other women of the same age in the general population.14 We therefore think that diuretics and blockers are still the drugs of choice in the treatment of arterial hypertension.
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